iifl-logo

Bal Pharma Ltd AGM

82.93
(0.13%)
Oct 9, 2025|12:00:00 AM

Bal Pharma CORPORATE ACTIONS

09/10/2024calendar-icon
09/10/2025calendar-icon
PurposeAGM DateAnnouncement Date
AGM25 Sep 202511 Aug 2025
Board of Directors of the Company has met today and inter alia transacted the following business, 1. Approved the unaudited financial results ( standalone and consolidated ) for the quarter ended 30.06.2025. 2. Convened 38th Annual General meeting of the company on 25th September 2025 at 11.30 am through AV means. 3. Decided to close the register of members from 19.09.2025 to 25.09.2025 ( both days inclusive ) 4. Approved the ESOP -2025 plan, subject to the approval of shareholders. 5. e-Voting dates from 22.09.2025 to 24.09.2025, for the ensuing Annual General Meeting Outcome of the 38th Annual General Meeting of the Company. (As Per BSE Announcement Dated on: 25/09/2025)

Bal Pharma: Related News

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.